On the other hand, quercetin also suppresses the inflammatory response in IBD by inducing miR-369-3p, which reduces C/EBP-β, TNF-α, and IL6 levels in LPS-stimulated dendritic cells, demonstrating its potential as a therapeutic agent, as documented (162). The gene discussed is IL6; the disease is irritable bowel syndrome.